Exclusive

Publication

Byline

Location

US Patent Issued to The Research Foundation for The State University of New York, The Regents of the University of California on April 14 for "Rage antibodies, fragments and uses thereof" (New York, California Inventors)

ALEXANDRIA, Va., April 15 -- United States Patent no. 12,600,778, issued on April 14, was assigned to The Research Foundation for The State University of New York (Amherst, N.Y.) and The Regents of th... Read More


US Patent Issued to MACROGENICS on April 14 for "LAG-3-binding molecules and methods of use thereof" (Maryland, California Inventors)

ALEXANDRIA, Va., April 15 -- United States Patent no. 12,600,779, issued on April 14, was assigned to MACROGENICS INC. (Rockville, Md.). "LAG-3-binding molecules and methods of use thereof" was inven... Read More


US Patent Issued to Regeneron Pharmaceuticals on April 14 for "Anti-CD3 antibodies, bispecific antigen-binding molecules that bind CD3 and CD20, and uses thereof" (New York Inventors)

ALEXANDRIA, Va., April 15 -- United States Patent no. 12,600,780, issued on April 14, was assigned to Regeneron Pharmaceuticals Inc. (Tarrytown, N.Y.). "Anti-CD3 antibodies, bispecific antigen-bindin... Read More


US Patent Issued to BIOTHEUS on April 14 for "Anti-PD-L1 and PD-L2 antibody and derivatives and use thereof" (Chinese Inventors)

ALEXANDRIA, Va., April 15 -- United States Patent no. 12,600,782, issued on April 14, was assigned to BIOTHEUS INC. (Zhuhai, China). "Anti-PD-L1 and PD-L2 antibody and derivatives and use thereof" wa... Read More


US Patent Issued to Regeneron Pharmaceuticals on April 14 for "Anti-New York esophageal squamous cell carcinoma 1 (NY-ESO-1) antigen-binding proteins and methods of use thereof" (New York Inventors)

ALEXANDRIA, Va., April 15 -- United States Patent no. 12,600,783, issued on April 14, was assigned to Regeneron Pharmaceuticals Inc. (Tarrytown, N.Y.). "Anti-New York esophageal squamous cell carcino... Read More


US Patent Issued to Millennium Pharmaceuticals on April 14 for "Anti-Clec12A antibodies and uses thereof" (Massachusetts Inventor)

ALEXANDRIA, Va., April 15 -- United States Patent no. 12,600,784, issued on April 14, was assigned to Millennium Pharmaceuticals Inc. (Cambridge, Mass.). "Anti-Clec12A antibodies and uses thereof" wa... Read More


US Patent Issued to Antlera Therapeutics on April 14 for "Method of screening for compounds that inhibit proliferation of pancreatic cancer cells having a loss-of-function mutation in the RNF43 gene" (Canadian Inventors)

ALEXANDRIA, Va., April 15 -- United States Patent no. 12,600,785, issued on April 14, was assigned to Antlera Therapeutics Inc. (Foster City, Calif.). "Method of screening for compounds that inhibit ... Read More


US Patent Issued to R.G.C.C. Holdings on April 14 for "C-met and TMX2 antibodies" (Swiss Inventor)

ALEXANDRIA, Va., April 15 -- United States Patent no. 12,600,786, issued on April 14, was assigned to R.G.C.C. Holdings AG (Zug, Switzerland). "C-met and TMX2 antibodies" was invented by Ioannis Papa... Read More


US Patent Issued to Horizon Therapeutics Ireland DAC on April 14 for "Methods for the treatment of thyroid eye disease" (Illinois, California, Puerto Rico Inventors)

ALEXANDRIA, Va., April 15 -- United States Patent no. 12,600,787, issued on April 14, was assigned to Horizon Therapeutics Ireland DAC (Dublin). "Methods for the treatment of thyroid eye disease" was... Read More


US Patent Issued to Viridian Therapeutics on April 14 for "Compositions and methods for treatment of thyroid eye disease" (Massachusetts, Puerto Rico Inventors)

ALEXANDRIA, Va., April 15 -- United States Patent no. 12,600,788, issued on April 14, was assigned to Viridian Therapeutics Inc. (Waltham, Mass.). "Compositions and methods for treatment of thyroid e... Read More